Open main menu

Biolecture.org β

Changes

Nimblegen

160 bytes removed, 23:02, 6 November 2007
no edit summary
<p>The company also owns a majority of the American biotechnology company Genentech and the Japanese biotechnology company Chugai Pharmaceuticals.</p>
<p>Roche Holding AG (ticker ROC.S) is listed on the London-based virt-x stock exchange (virt-x is a company of the SWX Swiss Exchange). Roche's revenues during fiscal year 2005 were $28.6 billion (2005, 35.5bn CHF). Descendants of the founding Hoffmann and Oeri families own half of the company. Swiss pharma company Novartis owns 33% of the company (as of 2005).</p>
<script type="text/javascript">//<![CDATA[ if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } //]]></script>
<p>&nbsp;</p>
<h2><span class="mw-headline">History</span></h2>
<h2><span class="mw-headline">References</span></h2>
<ol class="references">
<li id="_note-fundingroche"><strong><a title="" href="http://en.wikipedia.org/wiki/Nimblegen#_ref-fundingroche_0">^</a></strong> <a class="external text" title="http://www.fundinguniverse.com/company-histories/Roche-Biomedical-Laboratories-Inc-Company-History.html" rel="nofollow" href="http://www.fundinguniverse.com/company-histories/Roche-Biomedical-Laboratories-Inc-Company-History.html" rel="nofollow">Roche Biomedical Laboratories, Inc.</a>, FundingUniverse.com </li> <li id="_note-sec950515"><strong><a title="" href="http://en.wikipedia.org/wiki/Nimblegen#_ref-sec950515_0">^</a></strong> <a class="external text" title="http://www.secinfo.com/ds2yr.a4.htm" rel="nofollow" href="http://www.secinfo.com/ds2yr.a4.htm" rel="nofollow">Laboratory Corp of America Holdings &middot; 10-Q &middot; For 3/31/95</a>, SECInfo.com, Filed On 5/15/95, SEC File 1-11353, Accession Number 920148-95-11 </li> <li id="_note-royalty"><strong><a title="" href="http://en.wikipedia.org/wiki/Nimblegen#_ref-royalty_0">^</a></strong> &quot;<a class="external text" title="http://www.redherring.com/Article.aspx?a=14507&amp;hed=Roche%2C+Gilead+End+Tamiflu+Feud" rel="nofollow" href="http://www.redherring.com/Article.aspx?a=14507&amp;hed=Roche%2C+Gilead+End+Tamiflu+Feud" rel="nofollow">Roche, Gilead End Tamiflu Feud</a>&quot;, Red Herring, November 16, 2005.<span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&amp;rft.type=newspaperArticle&amp;rft.subject=News&amp;rft.title=Roche%2C+Gilead+End+Tamiflu+Feud&amp;rft.identifier=http%3A%2F%2Fwww.redherring.com%2FArticle.aspx%3Fa%3D14507%26hed%3DRoche%252C%2BGilead%2BEnd%2BTamiflu%2BFeud&amp;rft.publisher=Red+Herring&amp;rft.date=November+16%2C+2005">&nbsp;</span> </li>
</ol>
<ul>
<li>Hans Conrad Peyer (1996) <em>Roche - A Company History 1896-1996</em> Basel: Editiones Roche <a class="internal" href="http://en.wikipedia.org/w/index.php?title=Special:Booksources&amp;isbn=3907770595">ISBN 3 907770 59 5</a> </li>
</ul>
0
edits